CervoMed
CRVO
45 hedge funds and large institutions have $13.7M invested in CervoMed in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 18 reducing their positions, and 14 closing their positions.
1.27% less ownership
Funds ownership: 26.24% → 24.97% (-1.3%)
6% less funds holding
Funds holding: 48 → 45 (-3)
21% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 14
35% less capital invested
Capital invested by funds: $20.9M → $13.7M (-$7.24M)
61% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$2.03M |
| 2 |
Millennium Management
New York
|
+$648K |
| 3 |
Jane Street
New York
|
+$562K |
| 4 |
Goldman Sachs
New York
|
+$181K |
| 5 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
+$119K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$2.08M |
| 2 |
State Street
Boston,
Massachusetts
|
-$794K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$530K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$329K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$312K |
CRVO Hedge Fund Activity: Q2 2025 in Review
45 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q2 2025, worth a combined $13.7M — down 35% from $20.9M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of CRVO and 11 opened new positions — a net loss of 3 holders — while 18 trimmed existing stakes and 7 added.
The largest buyer was Morgan Stanley, adding an estimated $2.03M. The largest seller was BlackRock, cutting an estimated $2.08M.
- 45 institutional investors held CervoMed (CRVO) as of Q2 2025, down from 48 in Q1 2025.
- Funds reported $13.7M of CervoMed stock for Q2 2025, down 35% quarter-over-quarter.
- 11 funds opened new CervoMed positions in Q2 2025 and 14 closed out, a net change of -3 holders.
- The largest CervoMed buyer in Q2 2025 was Morgan Stanley, an estimated $2.03M added.
- The largest CervoMed seller in Q2 2025 was BlackRock, an estimated $2.08M sold.
Based on aggregated 13F filings for Q2 2025.